Curogene Life Sciences

Developer of drugs for eye disorders

placeCheongju-si, Chungcheongbuk-do, South Korea calendar_todayFounded 2018 language curogenels.com

Innovation

3 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 40 times.

YearFilings
20181
20193
20202
20211
20232

Investor mix

3 investors on record; lead investors include ActnerLab.

Investor typeCountShare
Venture capital267%
Accelerator & incubator133%
Coming soon